Literature DB >> 4901743

Changing faecal population of Escherichia coli in hospital medical patients.

E M Cooke, S Ewins, R A Shooter.   

Abstract

Specimens of faeces were obtained at weekly intervals for one year from patients in a female medical ward and Escherichia coli present were typed. The faecal E. coli population of the patients was constantly changing. No serotypes of E. coli were dominant, but on 31 occasions during the year small clusters of patients carried the same type.

Entities:  

Mesh:

Year:  1969        PMID: 4901743      PMCID: PMC1630066          DOI: 10.1136/bmj.4.5683.593

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  STUDIES ON THE EPIDEMIOLOGY OF ESCHERICHIA COLI INFECTIONS. IV. EVIDENCE FOR A NOSOCOMIAL FLORA.

Authors:  R P KENNEDY; J J PLORDE; R G PETERSDORF
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

2.  The importance of sample size in studies based upon the serologic classification of escherichia coli.

Authors:  K L VOSTI; A S MONTO; L A RANTZ
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

3.  Persistence of individual strains of Escherichia coli in man and dog under varying conditions.

Authors:  H J SEARS; H JANES; R SALOUM; I BROWNLEE; L F LAMOREAUX
Journal:  J Bacteriol       Date:  1956-03       Impact factor: 3.490

4.  Persistence of individual strains of Escherichia coli in the intestinal tract of man.

Authors:  H J SEARS; I BROWNLEE; J K UCHIYAMA
Journal:  J Bacteriol       Date:  1950-02       Impact factor: 3.490

5.  Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa.

Authors:  R A Shooter; H Gaya; E M Cooke; P Kumar; N Patel; M T Parker; B T Thom; D R France
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321

6.  Studies on the epidemiology of Escherichia coli infections. V. Factors influencing acquisition of specific serologic groups.

Authors:  R H Winterbauer; M Turck; R G Petersdorf
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

  6 in total
  25 in total

1.  Isolation and comparison of Escherichia coli strains from canine and human patients with urinary tract infections.

Authors:  D A Low; B A Braaten; G V Ling; D L Johnson; A L Ruby
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

2.  Effect of amoxicillin-clavulanate and cephradine on the fecal flora of healthy volunteers not exposed to a hospital environment.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

3.  Infection associated with modern surgical procedures.

Authors:  D Shaw
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

4.  High frequency of antimicrobial resistance in human fecal flora.

Authors:  S B Levy; B Marshall; S Schluederberg; D Rowse; J Davis
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Escherichia coli in retail processed food.

Authors:  J A Pinegar; E M Cooke
Journal:  J Hyg (Lond)       Date:  1985-08

6.  Escherichia coli serotypes throughout the gastrointestinal tract of patients with intestinal disorders.

Authors:  S Tabaqchali; A Howard; C H Teoh-Chan; K A Bettelheim; S L Gorbach
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

7.  The distribution of Bacteroides fragilis serotypes amongst clinical strains.

Authors:  K M Elhag; S Tabaqchali
Journal:  J Hyg (Lond)       Date:  1978-08

8.  Epidemiological study of klebsiella infection in the special care baby unit of a London hospital.

Authors:  E Riser; P Noone; F M Howard
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

9.  Escherichia coli in a maternity ward.

Authors:  S M O'Farrell; S M Lennox-King; K A Bettelheim; E J Shaw; R A Shooter
Journal:  Infection       Date:  1976       Impact factor: 3.553

10.  The acquisition of Escherichia coli by new-born babies.

Authors:  K A Bettelheim; S M Lennox-King
Journal:  Infection       Date:  1976       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.